Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception

[1]  M. Ko,et al.  Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys. , 2009, The journal of pain : official journal of the American Pain Society.

[2]  David G. Lambert,et al.  The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential , 2008, Nature Reviews Drug Discovery.

[3]  S. Sakurada,et al.  Effects of intraplantar injections of nociceptin and its N-terminal fragments on nociceptive and desensitized responses induced by capsaicin in mice , 2005, Peptides.

[4]  R. Przewłocki,et al.  Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat , 2005, Pain.

[5]  M. Schäfer,et al.  Morphine and endomorphin-1 differently influence pronociceptin/orphanin FQ system in neuropathic rats , 2004, Pharmacology Biochemistry and Behavior.

[6]  G. Calo’,et al.  Nociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy? , 2003, Journal of Pharmacology and Experimental Therapeutics.

[7]  K. Tan-No,et al.  Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study. , 2002, Biochemical pharmacology.

[8]  F. Sundler,et al.  Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord , 2002, Brain Research.

[9]  E. Ongini,et al.  Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. , 2002, European journal of pharmacology.

[10]  Xiao-jun Xu,et al.  Intrathecal [Nphe1]nociceptin( 1-13)NH2 selectively reduces the spinal inhibitory effect of nociceptin. , 2002, Life sciences.

[11]  E. Ongini,et al.  The putative OP4 antagonist, [Nphe1]nociceptin(1-13)NH2, prevents the effects of nociceptin in neuropathic rats , 2001, Brain Research.

[12]  T. Yamamoto,et al.  Antagonism of ORLI receptor produces an algesic effect in the rat formalin test. , 2001, Neuroreport.

[13]  G. Pasternak,et al.  Autoradiographic localization of 125I[Tyr14]orphanin FQ/nociceptin and 125I[Tyr10]orphanin FQ/nociceptin(1–11) binding sites in rat brain , 2000 .

[14]  L. Terenius,et al.  Nociceptin/orphanin FQ metabolism and bioactive metabolites , 2000, Peptides.

[15]  S. Salvadori,et al.  Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist , 2000, British journal of pharmacology.

[16]  K. Tan-No,et al.  Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice , 2000, Neuroscience Letters.

[17]  G. Pasternak,et al.  Identification of a high‐affinity orphanin FQ/nociceptin(1–11) binding site in mouse brain , 1999, Synapse.

[18]  K. Tan-No,et al.  Nociceptin (1–7) antagonizes nociceptin‐induced hyperalgesia in mice , 1999, British journal of pharmacology.

[19]  K. Tan-No,et al.  Involvement of tachykinin NK1 receptors in nociceptin-induced hyperalgesia in mice , 1999, Brain Research.

[20]  H. Ueda,et al.  Nociceptin‐induced scratching, biting and licking in mice: involvement of spinal NK1 receptors , 1999, British journal of pharmacology.

[21]  G. Pasternak,et al.  Peripheral orphanin FQ/nociceptin analgesia in the mouse. , 1999, Life sciences.

[22]  M. Salis,et al.  Cardiovascular effects of nociceptin in unanesthetized mice. , 1999, Hypertension.

[23]  L. Terenius,et al.  Biotransformation of nociceptin/orphanin FQ by enzyme activity from morphine-naive and morphine-treated cell cultures , 1999, Brain Research.

[24]  J. Silberring,et al.  Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment , 1999, Peptides.

[25]  Xiao-jun Xu,et al.  Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation , 1998, Pain.

[26]  D. Grandy,et al.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more , 1998, Trends in Neurosciences.

[27]  D. Grandy,et al.  Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. , 1997, Journal of neurophysiology.

[28]  G. Pasternak,et al.  Pharmacological characterization of orphanin FQ/nociceptin and its fragments. , 1997, The Journal of pharmacology and experimental therapeutics.

[29]  G. Henderson,et al.  The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ. , 1997, Trends in pharmacological sciences.

[30]  S. Salvadori,et al.  Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. , 1997, Journal of medicinal chemistry.

[31]  K. Erb,et al.  Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test , 1997, Neuroreport.

[32]  E. Okuda‐Ashitaka,et al.  Characterization of nociceptin hyperalgesia and allodynia in conscious mice , 1997, British journal of pharmacology.

[33]  D. Swandulla,et al.  Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurones of the neonatal rat spinal cord , 1997, British Journal of Pharmacology.

[34]  S. Kimura,et al.  Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat , 1997, Neuroscience Letters.

[35]  A. Gintzler,et al.  Nociceptin (Orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia , 1997, Brain Research.

[36]  G. Pasternak,et al.  Spinal analgesic activity of orphanin FQ/nociceptin and its fragments , 1997, Neuroscience Letters.

[37]  J. Meunier,et al.  Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. , 1997, European journal of pharmacology.

[38]  D. Grandy,et al.  Bidirectional modulatory effect of orphanin FQ on morphine‐induced analgesia: antagonism in brain and potentiation in spinal cord of the rat , 1997, British journal of pharmacology.

[39]  D. Grandy,et al.  Involvement of endogenous Orphanin FQ in electroacupuncture‐induced analgesia , 1997, Neuroreport.

[40]  G. Pasternak,et al.  Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. , 1997, Biochemical and biophysical research communications.

[41]  B. Roques,et al.  Nociceptin/Orphanin FQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15 , 1997, Journal of neurochemistry.

[42]  M. Nishi,et al.  Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus. , 1996, Brain research. Molecular brain research.

[43]  Xiao-jun Xu,et al.  Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. , 1996, Neuroreport.

[44]  D. Grandy,et al.  Orphanin FQ acts as a supraspinal, but not a spinal, anti‐opioid peptide , 1996, Neuroreport.

[45]  E. Faber,et al.  Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro , 1996, British journal of pharmacology.

[46]  V. Chapman,et al.  Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo , 1996, British journal of pharmacology.

[47]  S. Childers,et al.  Identification of opioid receptor‐like (ORL1) peptide‐stimulated [35S]GTPγS binding in rat brain , 1996 .

[48]  M. Nishi,et al.  Structure and regional distribution of nociceptin/orphanin FQ precursor. , 1996, Biochemical and biophysical research communications.

[49]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[50]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[51]  M. Wick,et al.  Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. , 1995, Brain research. Molecular brain research.

[52]  D. Sibley,et al.  Molecular Cloning of a Novel G Protein‐Coupled Receptor Related to the Opiate Receptor Family , 1995, Journal of neurochemistry.

[53]  Robert Elde,et al.  Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ, and κ opioid receptors , 1994 .

[54]  C. Kozak,et al.  Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family , 1994, FEBS letters.

[55]  M. Mortrud,et al.  Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type , 1994 .

[56]  T. Miyata,et al.  cDNA cloning and regional distribution of a novel member of the opioid receptor family , 1994, FEBS letters.

[57]  G Vassart,et al.  ORL1, a novel member of the opioid receptor family , 1994, FEBS letters.

[58]  K. Tan-No,et al.  The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord , 1992, Neuropharmacology.

[59]  K. Tan-No,et al.  Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord. , 1991, The Journal of pharmacology and experimental therapeutics.

[60]  G. Wilcox,et al.  Intrathecal morphine in mice: a new technique. , 1980, European journal of pharmacology.

[61]  J. Silberring,et al.  In vivo metabolism of nociceptin/orphanin FQ in rat hippocampus. , 1999, Neuroreport.

[62]  H. Loh,et al.  Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord , 1996 .